The Omicron variant of SARS-CoV-2 was first reported in November 2021 and has since been the dominant strain causing the most cases of COVID-19 in British Columbia. Bivalent COVID-19 vaccines are modified versions of the original COVID-19 vaccine. The bivalent COVID-19 vaccine targets the spike proteins found in both the original strain of SARS-CoV-2 and the Omicron variant. Join us on October 18 as we learn about the epidemiology of the COVID-19 disease, evaluate the evidence supporting the use of mRNA COVID-19 vaccines and learn how the different bivalent vaccines represent the next evolution of the mRNA platform.
At the end of this program, participants will be better able to:
- Describe the current epidemiology of COVID-19 disease.
- Evaluate the evidence supporting the use of mRNA COVID-19 vaccines.
- Demonstrate how bivalent vaccines represent the next evolution of the mRNA platform.
- Outline a practical approach for fall booster programs.
About the speaker: Tiana Tilli
Tiana received her Doctor of Pharmacy from the University of Toronto. While earning her degree, she participated in advocacy efforts while interning at the World Health Organization (WHO), Ontario Pharmacists’ Association, and St. Mary’s Hospital Lacor in Uganda. Upon graduating, Tiana completed a hospital pharmacy residency at St. Michael’s Hospital in Toronto. Tiana has held the position of Director of Pharmacy Innovation & Professional Affairs at Whole Health Pharmacy Partners, a community pharmacy banner, where she led the banner’s adult immunization program. This included developing continuing education resources on immunizations and operational supports for pharmacists as well as in-pharmacy awareness campaigns for patients. Tiana is currently a clinical pharmacist and lecturer at the University of British Columbia’s Pharmacists Clinic. Tiana is passionate about optimizing the role of pharmacists and providing patient-centered care.
This program is non-accredited. Total learning hours is estimated at 1.0 hours. Participants will receive a letter of participation after completion of the survey at the end of the webinar.
This learning program received a financial support from Moderna. This event will be moderated by Ann Johnston (MPharm, RPh), Senior Manager, Pharmacy Practice Support at the BC Pharmacy Association.
This event is complimentary to members.
Registration closes an hour prior to the start of the webinar, at 5:00 PM. On the day of the webinar, you will receive a link to the webinar by email. The email will come from email@example.com and could be in your junk folder.
Please Note: A BCPhA account is required to register for this event. If you do not have a login account or if you are unsure if you have a login, please fill out the Account Creation Form and a member of the BCPhA team will contact you. Accounts can be created free of charge with valid College registration.